Navigation Links
WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry

Cypress, CA, Costa Mesa, CA, Langhorne, PA, Garden City, NY (PRWEB) January 02, 2013

WCCT Global, a Full Service Contract Research Organization (CRO) supporting Phase I - IV biopharmaceutical and device development has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the US to help them enhance the capabilities of the VCT Clinical Trials Database Registry system. This new enhancement designed in collaboration with WCCT enables the Investigator to document study-participant adherence to medication schedules. Mel Affrime, Sr. VP R&D, WCCT said, “Patient adherence to clinical research protocol procedures, is critical along with returning to the investigational site for study procedures and safety assessments. This added enhancement now offered by VCT adds another level of security in the validity of the data that we capture for our clients”.

Mitchell Efros, MD, FACS, CEO and President of Verified Clinical Trials, stated "The recently released study medication adherence reminder system will improve dosing compliance in clinical trials. The module has the ability to remind the research volunteer to take the medication directly through the VCT registry. There is also the option of having the research subject respond to the reminder signaling their compliance and execution of the required dosing. WCCT Global, one of the early subscribers to our database, has always been an industry leader in their efforts to ensure the safety of their study participants and the quality of their clinical data. It has been a pleasure working with the WCCT team to make this enhancement available to our entire network of subscribers.”

About WCCT Global

WCCT Global is a multi-site, Full Service global Contract Research Organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive to for tomorrow’s therapies to be available today,” truly exemplifies the focus and reason for their cutting edge work. As a drug development partner, WCCT Global partners with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support with an emphasis on overseeing and executing on trials in special disease populations, ethnobridging volunteers, and cardiac safety . In addition, they extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Ophthalmology, Oncology, Renal, Serial ECGs, and Vaccines. Visit WCCT Global on the web at

Contact for WCCT Global

Talia Nikolao
Vice President, Business Development

About Verified Clinical Trials:

Verified Clinical Trials was developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of clinical trial database registries. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities.

To RSVP or for more information, visit

Verified Clinical Trials Contact Info
Kerri Weingard, ANP, Chief Operating Officer
Verified Clinical Trials +1 516 998-7499

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) ... remaining 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) ... B Warrants") subject to the previously disclosed November ... 2015, which will result in the issuance of ... the issuance of such shares, there will be ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies ... being named to Deloitte's 2015 Technology Fast 500 list of the fastest growing ... a FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):